Onxeo Reports Decision from the Paris Court of Appeal in the Lawsuit against SpeBio/SpePharm - Business Wire

Onxeo Reports Decision from the Paris Court of Appeal in the Lawsuit against SpeBio/SpePharm  Business Wire

Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), a clinical-stage biotechnology company specializing in the development of ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2QUgqfK